MD FCCP FAAHPM | Levine Cancer Institute | United States
Dr. Mellar Pilgrim Davis, MD, FCCP, FAAHPM, is a distinguished physician specializing in oncology, hematology, and palliative medicine. With decades of experience in clinical practice, research, and education, he has made significant contributions to supportive cancer care. Dr. Davis has held key academic and clinical positions at renowned institutions, impacting patient care and medical education worldwide.
Profile👤
Scopus
Strengths for the Awards✨
-
Extensive Research and Publications 📚
- Dr. Davis has a prolific research career, with significant contributions in oncology, palliative care, and pain management.
- Recognized as a World Expert in Analgesics (Top 0.1% of scholars per Expertscape).
- Highly ranked in Symptomatic Treatment (#4) and Palliative Care (#21) by ScholarGPS.
-
Significant Impact in Palliative Medicine 🌿
- Held leadership roles in the Multinational Association of Supportive Care in Cancer (MASCC), including Chair of the Pain Subgroup.
- Developed guidelines and educational programs for pain and opioid management in cancer care.
- Recognized for outstanding contributions to cancer pain management by MD Anderson Cancer Center (2023).
-
Recognized Excellence in Teaching and Mentorship 🎓
- Multiple Teacher of the Year awards in Cleveland Clinic and Geisinger.
- Full Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine.
-
Leadership and Professional Influence 🌍
- Served on NCI, ASCO, ACS, and NCCN panels, shaping research and clinical practice in oncology and palliative care.
- Co-Chair of the International Conference on Opioids, advancing pain research.
Education🎓
Dr. Davis earned his Bachelor of Science degree from Otterbein College in 1974 and his MD from Ohio State Medical College in 1977. He further honed his expertise through rigorous postdoctoral training, including an Internal Medicine residency at Riverside Methodist Hospital and a Hematology/Oncology fellowship at Mayo Clinic.
Experience👩⚕️
Over the years, Dr. Davis has served in various prestigious medical institutions. His career journey includes roles at Toledo Clinic, Milhon Clinic, Columbus Oncology Associates, Cleveland Clinic, and Geisinger Medical Center. Additionally, he has held academic appointments as a Professor of Medicine at Cleveland Clinic Lerner School of Medicine and as a Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine
📝 Dr. Davis’s research focuses on palliative medicine, oncology symptom management, pain control, and ethical issues in cancer care. His work has influenced medical guidelines and practices worldwide, especially in the fields of palliative care and supportive oncology.
Awards and Honors🏆
Dr. Davis has received numerous awards, including the Compassion in Medicine Award, multiple “Best Doctors in America” recognitions, and the Distinguished Service Award from the Multinational Association of Supportive Care in Cancer. He has also been acknowledged as a world expert in analgesics and palliative care.
Publications📚
-
Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics
- Authors: M.P. Davis, N. Bader, J.L. Basting, B. Lagerman, M.J. Wojtowicz
- Publication Year: 2025
-
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits
- Authors: M.P. Davis
- Publication Year: 2025
-
Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study
- Authors: M.P. Davis, A.M. Ulrich, R. Segal, B.A. Bauer, C.L. Loprinzi
- Publication Year: 2024
-
Respiratory Depression Associated with Opioids: A Narrative Review
- Authors: M.P. Davis, S.L. DiScala, A. Davis
- Publication Year: 2024
-
The Surprise Question: Not Ready for Prime Time
- Authors: M.P. Davis
- Publication Year: 2024
-
Correction to: Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline
- Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
- Publication Year: 2024
-
Understanding The Number Needed to Treat
- Authors: M.P. Davis, E.A. Vanenkevort
- Publication Year: 2024
-
Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline
- Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
- Publication Year: 2024
-
Fentanyl Pharmacokinetic Paradoxical in Cancer Cachexia
- Authors: M.P. Davis
- Publication Year: 2024
Conclusion🎯
Dr. Mellar Pilgrim Davis has dedicated his career to improving cancer care and palliative medicine. Through his extensive research, clinical expertise, and commitment to education, he has left an enduring impact on patient care and medical knowledge. His legacy continues to inspire healthcare professionals worldwide.
